30
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73007 |
PARP10-IN-2
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
PARP10-IN-2 是一种有效的单-ADP-核糖基转移酶 PARP10 抑制剂,对人 PARP10 的 IC50 值为 3.64 μM。PARP10-IN-2 对 PARP2 和 PARP15也具有抑制作用, IC50 分别为 27 μM 和 11 μM。 | |||
T9777 |
THP104c
|
Mitochondrial Metabolism | Metabolism |
THP104c 是有效的线粒体分裂抑制剂。 | |||
T72553 |
ARTD10/PARP10-IN-1
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
ARTD10/PARP10-IN-1 是一种强效性的 PARP 抑制剂,抑制单 ADP 核糖转移酶 ARTD7/PARP15,ARTD8/PARP14,ARTD10/PARP10 和聚 ADP-核糖聚合酶-1 (ARTD1/PARP1),具有潜在的抗癌抗肿瘤活性,可用于研究前列腺癌和乳腺癌。 | |||
T67932 |
PARP10-IN-3
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
PARP10-IN-3 是一种有效且具有选择性的单-ADP-核糖基转移酶 PARP10 抑制剂,对人 PARP10 具有抑制作用( IC50 :480 nM)。PARP10-IN-3 对人 PARP2 和 人 PARP15也具有抑制作用, IC50 值都是 1.7 μM。 | |||
T73447 |
NP10679
|
P450; HER; NMDAR; Histamine Receptor | Angiogenesis; GPCR/G Protein; Immunology/Inflammation; JAK/STAT signaling; Metabolism; Neuroscience; Tyrosine Kinase/Adaptors |
NP10679 是一种可口服且具有选择性、脑穿透性、高效性和 pH 敏感性的 GluN2B 亚基的 N-methyl-D-aspartate (NMDA) 受体抑制剂。NP10679 抑制 histamine H1 、 hERG 通道和 CYP 酶,可用于研究癫痫和缺血性卒中。 | |||
T2156 |
WP1066
|
Apoptosis; JAK; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
WP1066 是一种新型JAK2和STAT3抑制剂,对 STAT5 和 ERK1/2 也起作用。它用于研究黑色素瘤、脑癌、实体瘤和中枢神经系统肿瘤治疗。 | |||
T80290 |
PP102
|
||
PP102为一种抗菌肽,针对革兰氏阴性及革兰氏阳性细菌展现出抗菌效能,具体作用于B. subtilis(MIC: 25 uM)、S. aureus(MIC: 13 uM)、S. lutea(MIC: 63 uM)和B. pumilu(MIC: 23 uM)。 | |||
T75811 |
PBP10 TFA
|
||
PBP10是一种细胞通透性和选择性的gelsolin衍生的肽抑制剂,针对甲酰基肽受体2(FPR2)具有较高选择性,相较于FPR1更为优选。该化合物为N端偶联罗丹明的10个氨基酸肽,对革兰氏阳性及革兰氏阴性菌均展现出杀菌活性,同时能够抑制微生物诱导的炎症反应。 | |||
TP2145 |
JTP10-△-R9 TFA
|
JNK | MAPK |
JTP10-△-R9 TFA is a selective inhibitor of JNK2 peptide (IC50: 89 nM), exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3. | |||
T74445 |
ZA3-Ep10
|
||
ZA3-Ep10是一种两性离子的脂质,用于合成脂质纳米颗粒,用于体内 RNA 传递和非病毒 CRISPR/Cas 基因编辑。 | |||
TP1574 |
Gp100 (619-627)
Gp100 619-627 |
||
This is a HLA-A*0201 restricted epitope used in melanoma studies. | |||
TP1948 |
PBP10
PBP 10 |
||
Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exh | |||
T27848 |
LP10
LP-10,LP 10 |
||
LP10 is a reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1 and a Potent type II inhibitor of Trypanosoma cruzi CYP51. | |||
T11210 |
EP1013
F1013 |
Caspase | Apoptosis; Proteases/Proteasome |
EP1013 is a broad-spectrum selective inhibitor of Caspase used in the study of type 1 diabetes. | |||
T39569 |
Gp100 (25-33), mouse
Mgp100 (25-33),Gp100 (25-33), mouse |
||
Gp100 (25-33) corresponds to residues 25 to 33 of the mouse self/tumor antigen glycoprotein (mgp100), which is an enzyme responsible for pigment synthesis. This epitope fragment is found in both normal melanocytes and melanoma cells. | |||
TP2146 |
JTP10-△-TATi TFA
|
JNK | MAPK |
JTP10-△-TATi TFA is a selective inhibitor of JNK2 peptide (IC50: 92 nM), exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3. | |||
T32417 |
KP1019
FFC14A,KP 1019,indazolium trans-tetrachlorobis(1H-indazole)ruthenate-(III) |
||
KP1019 is now discontinued. | |||
T82743 |
CFP10 (71–85)
|
||
CFP10 (71–85) 是具生物活性的肽类,能激活表达不同MHC II类与I类分子的人类CD4+和CD8+ T细胞,诱导IFN-γ产生及CTL活性。(CFP10 71–85). | |||
T60309 | PARP10/15-IN-3 | ||
PARP10/15-IN-3 (Compound 8a) 是一种有效的PARP10和PARP15双重抑制剂,对 PARP10 和 PARP15 的IC50值分别为 0.14 μM 和 0.40 μM。PARP10/15-IN-3 可以进入细胞并使细胞免于凋亡 (apoptosis)。 | |||
T60495 | PARP10/15-IN-1 | ||
PARP10/15-IN-1 (化合物 8l) 是PARP10和PARP15的有效的双重抑制剂,其IC50值分别为 160 nM 和 370 nM,用于癌症领域的研究。 | |||
TP1416 |
Gp100 (25-33), human TFA (212370-40-6 free base)
Gp100 (25-33), human TFA |
||
Gp100 (25-33), human TFA is a 25-33 amino acid fragment of human melanoma antigen.Gp100 (25-33), human TFA is a 9-amino acid (AA) epitopes restricted by h-2db and recognized by T cells. | |||
T73361 |
RP101988
|
||
RP101442为Ozanimod的主要活性代谢物,具有高选择性的S1PR1激动剂属性,其对S1PR1和S1P5R的EC50值分别为0.19 nM与32.8 nM。 | |||
T73360 |
RP101442
|
||
RP101442 是 Ozanimod 的活性代谢物,是一种选择性强的 S1PR1激动剂,对 S1PR1和 S1PR5的 EC50分别为 2.6 nM 和 171 nM。 | |||
T81279 |
RhB-PBP10 TFA
|
||
RhB-PBP10 TFA,一种Rhodamine B 标记的PBP10 TFA (FPR2 拮抗剂),有效选择性地抑制FPRL1 在中性粒细胞中诱导的颗粒动员以及氧自由基的分泌。 | |||
TP1727 |
Gp100 (25-33), human
|
||
Gp100 (25-33), human is the amino acids 25-33 fragment of the human melanoma antigen. It is a 9-amino acid (AA) epitope restricted by H-2Db and recognized by the T cells.This is amino acids 25 to 33 fragment of human melanoma antigen gp100. This H-2Db res | |||
T60567 | PARP10/15-IN-2 | ||
PARP10/15-IN-2 (Compound 8h) 是 PARP10和 PARP15的双重抑制剂,IC50值分别为 0.15 μM 和 0.37 μM。PARP10/15-IN-2 可以进入细胞并使细胞免于凋亡。 | |||
T83685 |
UFP101 TFA
|
||
UFP101是一种合成肽类物质,作为nociceptin受体的拮抗剂(Ki为0.06 nM,测试于表达人类受体的CHO细胞中)。它对nociceptin受体的选择性高于κ-opioid受体(Ki为204 nM,测试于表达大鼠受体的CHO细胞中)。UFP101能抑制表达于CHO细胞膜的nociceptin受体释放GTPγS(EC50为1.86 nM)。通过脑室内给药,UFP101(10 nmol/每只动物)能延长小鼠尾巴甩动试验中的尾巴撤回潜伏期。在由盲肠结扎和穿刺诱发的小鼠败血症模型中,UFP101(0.003、0.03及0.3 mg/kg)能提高生存率。 | |||
T78593 |
JP104
|
FAAH | Metabolism; Neuroscience |
JP104为一种氨基甲酸芳基酯类化合物,其具有不可逆FAAH抑制作用,显示出约为8的pIC50值。 | |||
T72554 |
ARTD10/PARP10-IN-2
|
||
ARTD10/PARP10-IN-2 是一种强效、非选择性的PARP 抑制剂。ARTD10/PARP10-IN-2 靶向单 ADP 核糖转移酶 (ARTD10/PARP10) 和聚 ADP-核糖聚合酶-1 (ARTD1/PARP1),IC50分别为 2.0 μM,和 9.7 μM。 | |||
TP1805 |
T7 Tag Peptide
|
||
T7 Tag Peptide 是一个由T7噬菌体编码的蛋白p10前导序列的11个氨基酸标记蛋白,可以被T7 tag标签抗体特异性识别,可用于不同的免疫检测以及亲和纯化。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2358 |
Fructo-oligosaccharide DP10/GF9
蔗果十糖,Fructo-oligosaccharide DP10/GF9 |
Others | Others |
Fructo-oligosaccharide DP10/GF9 is a compound classified as a fructooligosaccharide (FOS) with a degree of polymerization (DP) of 10. FOS consists of a chain of 9 fructose units connected by (2→1)-β-glycosidic bonds, with a lone D-glucosyl unit located at the non-reducing end. |